Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study
Journal of multidisciplinary healthcare , 7 , 489501
The slightly less certain part is that you'll need to enroll in a Medicare Part D plan that participates in BALANCE to keep your coverage
This article breaks down what you need to know about using these two drugs together, including potential risks and how to get the right care
Combats Fine Lines: Improves skin elasticity for a youthful glow
Oral Semaglutide (Wegovy Pill) - FDA Approved December 2025: According to the OASIS 4 trial published in the New England Journal of Medicine, participants who took the Wegovy pill experienced 13.6% mean weight loss over approximately 64 weeks when including all participants regardless of adherence, compared to 2.2% for those taking placebo